Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein.
about
Intracellular events and cell fate in filovirus infectionEbolavirus glycoprotein structure and mechanism of entryAnti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virusSteric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum.An update on the use of antibodies against the filoviruses.Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus.RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.Ebola Virus GP Gene Polyadenylation Versus RNA Editing.Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivityThe roles of ebolavirus glycoproteins in viral pathogenesis.Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.Filovirus Strategies to Escape Antiviral Responses.Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection.Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo.Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.
P2860
Q22305521-871A1AD4-2088-49F3-BD89-99F27D1DA58FQ27490991-15575F8B-80B6-4555-B507-E7158BA950E6Q30252022-5FC28B7C-A4B0-4C29-ADAE-8EAE7159CCF8Q33733844-E0EB7F1D-EE4C-4CFE-91F4-21B71640D255Q34115190-D1303153-95D5-4E17-AADA-9F7867ACE6DFQ34463780-609D46C9-B9C7-472B-934D-14CBFD88B3AFQ34510420-AFA1F197-8E9E-495E-A34C-07329042B77DQ34657170-82C5F481-D060-4004-80DA-49501A52F02EQ35299756-927D7E34-3339-4F0A-A164-04222E1BBE4FQ35823426-2DFE1679-7E4A-4E3E-9526-343DDF56E713Q35955731-7767542A-7885-4B6F-9CD9-6BC066018033Q37115285-F9415651-2AF9-44C5-9C72-4DD10A183EFDQ37333887-060398E5-42F2-4983-A775-86CC0735337DQ37667895-E1848F6A-3BAE-45F3-B330-4500F36DA031Q38857149-231DF889-8910-4377-AE26-030FABCDF96EQ38861989-9B4150DB-9BF8-4442-84D8-EBC058D4B93DQ38891399-4B8CDA15-F2CF-43B4-9B08-0ABEDFC7E61EQ38940832-0D6BFA77-445A-4AB6-98D9-06256DD6524DQ39010678-D4EC2369-50E6-4EEF-AC69-FB8D4ECFC587Q39383826-494B4CB9-19BA-4FBD-9C17-42AD944090DEQ40132236-44AD3584-B345-462E-964E-62A6DD7C06AAQ40148056-99CD52D9-E1F1-4D16-A7DC-BB83A95C8D82Q41822299-1BC3E94F-9442-4477-B9B4-E9340088CCE1Q44105787-E90398C5-73C6-4F6A-802F-25489163A1C2Q45323703-E955B84D-B90D-40EE-A9F2-5FB87830AEB7
P2860
Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Requirements for cell rounding ...... n by Ebola virus glycoprotein.
@en
type
label
Requirements for cell rounding ...... n by Ebola virus glycoprotein.
@en
prefLabel
Requirements for cell rounding ...... n by Ebola virus glycoprotein.
@en
P2860
P1433
P1476
Requirements for cell rounding ...... n by Ebola virus glycoprotein.
@en
P2093
Joseph R Francica
Meghan K Matukonis
P2860
P304
P356
10.1016/J.VIROL.2008.10.029
P407
P50
P577
2008-11-14T00:00:00Z